Atherosclerotic Cardiovascular Diseases Completed Phase 3 Trials for Inclisiran (DB14901)
Also known as: Atherosclerotic Cardiovascular Disease / Atheromatosis / Atherosclerotic heart disease of native coronary artery / Atherosclerosis / Atherosclerosis (morphologic abnormality) / Arteriosclerotic vascular disease (disorder) / Arteriosclerosis / Arteriosclerosis (morphologic abnormality) / Vascular sclerosis (morphologic abnormality)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0078488 (Atherosclerotic Cardiovascular Diseases) | Completed | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT04929249 | A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE) | Treatment | |
| NCT04807400 | Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support | Health Services Research |